{
    "clinical_study": {
        "@rank": "11558", 
        "arm_group": [
            {
                "arm_group_label": "TIVc", 
                "arm_group_type": "Experimental", 
                "description": "A single 0.5 mL dose of vaccine administered intramuscularly"
            }, 
            {
                "arm_group_label": "TIVf", 
                "arm_group_type": "Active Comparator", 
                "description": "A single 0.5 mL dose of vaccine administered intramuscularly"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy children and adolescents\n      4 to 17 years of age."
        }, 
        "brief_title": "Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Influenza", 
            "Fever"
        ], 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Healthy subjects 4-17 years of age\n\n        Exclusion Criteria:\n\n          -  Subjects who are not healthy,\n\n          -  Subjects who are pregnant or breast feeding,\n\n          -  Subjects with a history of severe allergic reaction or allergic to any of the vaccine\n             components."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "2055", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857206", 
            "org_study_id": "V58_31", 
            "secondary_id": "U1111-1139-9440"
        }, 
        "intervention": [
            {
                "arm_group_label": "TIVc", 
                "intervention_name": "Mammalian cell based flu vaccine", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "TIVf", 
                "intervention_name": "Egg based flu vaccine", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Influenza", 
            "children and adolescents", 
            "trivalent vaccine", 
            "cell culture", 
            "embryonated chicken eggs"
        ], 
        "lastchanged_date": "January 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mobile", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36608"
                    }, 
                    "name": "320, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ponte Vedra", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32081"
                    }, 
                    "name": "312, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Augusta", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67010"
                    }, 
                    "name": "313, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newton", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67114"
                    }, 
                    "name": "305, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67207"
                    }, 
                    "name": "301, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67205"
                    }, 
                    "name": "302, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fremont", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68025"
                    }, 
                    "name": "311, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }, 
                    "name": "308, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44121"
                    }, 
                    "name": "317, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "74127"
                    }, 
                    "name": "309, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warwick", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02886"
                    }, 
                    "name": "314, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Pleasant", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29464"
                    }, 
                    "name": "319, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37620"
                    }, 
                    "name": "310, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37203"
                    }, 
                    "name": "318, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84124"
                    }, 
                    "name": "315, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84109"
                    }, 
                    "name": "304, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84121"
                    }, 
                    "name": "306, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Jordan", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84095"
                    }, 
                    "name": "303, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yamba", 
                        "country": "Australia", 
                        "state": "Australian Capital Territory", 
                        "zip": "2606"
                    }, 
                    "name": "102, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westmead", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2145"
                    }, 
                    "name": "100, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auchenflower", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4066"
                    }, 
                    "name": "108, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sherwood", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4075"
                    }, 
                    "name": "107, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Adelaide", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5006"
                    }, 
                    "name": "104, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carlton", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3010"
                    }, 
                    "name": "103, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Subiaco", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6008"
                    }, 
                    "name": "105, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Takapuna", 
                        "country": "New Zealand", 
                        "state": "Auckland", 
                        "zip": "0622"
                    }, 
                    "name": "151, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beckenham", 
                        "country": "New Zealand", 
                        "state": "Christchurch", 
                        "zip": "8024"
                    }, 
                    "name": "150, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muntinlupa City", 
                        "country": "Philippines", 
                        "state": "Alabang", 
                        "zip": "1781"
                    }, 
                    "name": "251, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muntinlupa City", 
                        "country": "Philippines", 
                        "state": "Alabang", 
                        "zip": "1781"
                    }, 
                    "name": "250, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muntinlupa City", 
                        "country": "Philippines", 
                        "state": "Alabang", 
                        "zip": "1781"
                    }, 
                    "name": "254, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manila", 
                        "country": "Philippines", 
                        "state": "Ermita", 
                        "zip": "1001"
                    }, 
                    "name": "253, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manila", 
                        "country": "Philippines", 
                        "state": "Sampaloc", 
                        "zip": "1001"
                    }, 
                    "name": "252, Novartis Investigation Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Khon Kaen", 
                        "country": "Thailand", 
                        "state": "Muang", 
                        "zip": "40002"
                    }, 
                    "name": "201, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "state": "Rajathevi", 
                        "zip": "10400"
                    }, 
                    "name": "200, Novartis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkoknoi", 
                        "country": "Thailand", 
                        "state": "Siriraj", 
                        "zip": "10700"
                    }, 
                    "name": "202, Novartis Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "New Zealand", 
                "Philippines", 
                "Thailand"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase III, Observer Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin\u00ae), in Healthy Children and Adolescents 4 to 17 Years of Age.", 
        "overall_official": {
            "affiliation": "Novartis Vaccines", 
            "last_name": "Novartis Vaccines and Diagnostics", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Thailand: Food and Drug Administration", 
                "Philippines : Food and Drug Administration", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "New Zealand: Medsafe"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Proportion of subjects reporting solicited local and systemic Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 to Day 7 for previously and not-previously vaccinated  subjects and Day 29 to Day 35 for not-previously vaccinated subjects"
            }, 
            {
                "measure": "Proportion of subjects reporting  Unsolicited Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 to Day 28 for previously and not-previously vaccinated subjects and Day 29 to Day 49 for not previously vaccinated subjects"
            }, 
            {
                "measure": "Proportion of subjects reporting Medically attended Adverse Events,, Adverse events leading to vaccine/ study withdrawl, new onset of chronic diseases and Serious Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 to Day 183 for previously vaccinated subjects and Day 213 for not-previously vaccinated subjects"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857206"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Vaccines", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}